Lesson plan
MSX 2+
MSX-2 is a selective adenosine A 2A receptor antagonist used in scientific research. It is a xanthine and a derivative of the non-selective adenosine receptor antagonist caffeine. The affinities (K i ) of MSX-2 for the human adenosine receptors are 5.38 to 14.5 nM for the adenosine A 2A receptor, 2,500 nM for the adenosine A 1 receptor (172- to 465-fold lower than for the A 2A receptor), and >10,000 nM for the adenosine A 2B and A 3 receptors (>690-fold lower than for the A 2A receptor). MSX-2 has poor water solubility, which has limited the use of MSX-2 itself. Water-soluble ester prodrugs of MSX-2, including MSX-3 (a phosphate ester prodrug) and MSX-4 (an amino acid ester prodrug), have been developed and used in place of MSX-2. MSX-3 is best-suited for use by intravenous administration, whereas MSX-4 can be administered by oral administration. MSX-3 and MSX-4 reverse motivational deficits in animals and hence have the capacity to produce pro-motivational effects. MSX-2 and MSX-3 were first described in the scientific literature by 1998. Subsequently, MSX-4 was developed and described by 2008.
Article summary
MSX-2 is a selective adenosine A 2A receptor antagonist used in scientific research. It is a xanthine and a derivative of the non-selective adenosine receptor antagonist caffeine. The affinities (K i ) of MSX-2 for the human adenosine receptors are 5.38 to 14.5 nM for the adenosine A 2A receptor, 2,500 nM for the adenosine A 1 receptor (172- to 465-fold lower than for the A 2A receptor), and >10,000 nM for the adenosine A 2B and A 3 receptors (>690-fold lower than for the A 2A receptor). MSX-2 has poor water solubility, which has limited the use of MSX-2 itself. Water-soluble ester prodrugs of MSX-2, including MSX-3 (a phosphate ester prodrug) and MSX-4 (an amino acid ester prodrug), have been developed and used in place of MSX-2. MSX-3 is best-suited for use by intravenous administration, whereas MSX-4 can be administered by oral administration. MSX-3 and MSX-4 reverse motivational deficits in animals and hence have the capacity to produce pro-motivational effects. MSX-2 and MSX-3 were first described in the scientific literature by 1998. Subsequently, MSX-4 was developed and described by 2008.
Key claims
- P11408: MSX2+ — source: Wikidata, item Q11232199, statement P11408, retrieved 2026-10-18 · confidence 0.95
- P155: Q11232203 — source: Wikidata, item Q11232199, statement P155, retrieved 2026-10-18 · confidence 0.95
- P156: Q11232214 — source: Wikidata, item Q11232199, statement P156, retrieved 2026-10-18 · confidence 0.95
- P279: Q853547 — source: Wikidata, item Q11232199, statement P279, retrieved 2026-10-18 · confidence 0.95
- P279: Q473708 — source: Wikidata, item Q11232199, statement P279, retrieved 2026-10-18 · confidence 0.95
- P31: Q317623 — source: Wikidata, item Q11232199, statement P31, retrieved 2026-10-18 · confidence 0.95
- P373: MSX2+ — source: Wikidata, item Q11232199, statement P373, retrieved 2026-10-18 · confidence 0.95
- P5936: 291 — source: Wikidata, item Q11232199, statement P5936, retrieved 2026-10-18 · confidence 0.95
- P646: /m/02_5b1d — source: Wikidata, item Q11232199, statement P646, retrieved 2026-10-18 · confidence 0.95
- P724: MSX_MSX_Plus_TOSEC_2012_04_23 — source: Wikidata, item Q11232199, statement P724, retrieved 2026-10-18 · confidence 0.95
- P7757: 117 — source: Wikidata, item Q11232199, statement P7757, retrieved 2026-10-18 · confidence 0.95
- P7757: 64 — source: Wikidata, item Q11232199, statement P7757, retrieved 2026-10-18 · confidence 0.95
- P7809: 191 — source: Wikidata, item Q11232199, statement P7809, retrieved 2026-10-18 · confidence 0.95
- P8025: ascii/msx2plus — source: Wikidata, item Q11232199, statement P8025, retrieved 2026-10-18 · confidence 0.95
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- The record states that the P11408 is "MSX2+". What evidence would count against this claim?
- The record states that the P155 is "Q11232203". What evidence would count against this claim?
- The record states that the P156 is "Q11232214". What evidence would count against this claim?
- The record states that the P279 is "Q853547". What evidence would count against this claim?
- The record states that the P279 is "Q473708". What evidence would count against this claim?
- The record states that the P31 is "Q317623". What evidence would count against this claim?
- The record states that the P373 is "MSX2+". What evidence would count against this claim?
- The record states that the P5936 is "291". What evidence would count against this claim?
- The record states that the P646 is "/m/02_5b1d". What evidence would count against this claim?
- The record states that the P724 is "MSX_MSX_Plus_TOSEC_2012_04_23". What evidence would count against this claim?
- The record states that the P7757 is "117". What evidence would count against this claim?
- The record states that the P7757 is "64". What evidence would count against this claim?
- The record states that the P7809 is "191". What evidence would count against this claim?
- The record states that the P8025 is "ascii/msx2plus". What evidence would count against this claim?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.